Repetitive transcranial magnetic stimulation to improve post-surgery thinking and memory in older adults
Official title: Impact of Repetitive Transcranial Magnetic Stimulation on Postoperative Neurocognitive Recovery in Older Patients With Preoperative Cognitive Impairment: A Randomized, Double-blinded, Sham-controlled Trial
Run by Peking University First Hospital · NCT06482749 · Data updated 2026-11-12
This trial will test whether repetitive transcranial magnetic stimulation (rTMS) given around the time of surgery helps older adults with mild-to-moderate cognitive impairment keep their thinking and memory after non-cardiac operations.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 568 (estimated) |
| Sponsor | Peking University First Hospital Academic / other |
| Locations | 3 sites (Beijing, Beijing Municipality and 2 other locations) |
| Status | Recruiting |
| Started | July 28, 2025 |
| Main results expected | August 2028 |
| Study ends | February 2029 |
| Registry record updated | July 31, 2025 |
| Trial ID | NCT06482749 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are right-handed adults aged 65 or older with mild-to-moderate preoperative cognitive impairment (MoCA >9 and <26) scheduled for elective non-cardiac surgery lasting more than two hours and who can remain in hospital and attend follow-up at the study site.
✕Probably not a fit
Patients with more severe or very mild cognition outside the MoCA range, those undergoing neurosurgery, or individuals with contraindications to rTMS (for example epilepsy, pacemaker or other implanted metal/electrical devices, pregnancy, left-handedness, or severe sensory/language impairments) are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial enrolls patients aged 65 and older with preoperative mild-to-moderate cognitive impairment (MoCA >9 and <26) who are scheduled for elective non-cardiac surgery expected to last more than two hours and require at least a five-day hospital stay. Participants are randomized to receive perioperative rTMS targeted to the left dorsolateral prefrontal cortex or a sham stimulation control. Cognitive outcomes of interest include rates of delayed neurocognitive recovery (DNR) and postoperative neurocognitive disorder (POCD) measured after surgery. The design compares active neural stimulation versus placebo-like sham to see if rTMS reduces early and later postoperative cognitive decline.
Why it matters
Potential benefit: If successful, this approach could reduce the risk of delayed cognitive recovery and longer-term postoperative cognitive problems in older patients with preexisting cognitive impairment.
How similar studies have gone: Prior trials and meta-analyses report cognitive benefits of rTMS in people with mild cognitive impairment and other cognitive disorders, but applying rTMS perioperatively to prevent DNR/POCD is relatively novel and less well tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged ≥65 years; 2. Patients with preoperative mild to moderate cognitive impairment, defined as 9\<Montreal Cognitive Assessment (MoCA)\<26; 3. Scheduled for elective non-cardiac surgery under general anesthesia, with an expected surgical duration of \>2 hours; 4. Expected to stay in hospital for at least 5 days after surgery. Exclusion Criteria: 1. Left-handed; 2. Primary school education level or below; 3. Comorbid diseases including mental illness, intellectual disability, auditory and visual dysfunction, language impairment, severe neurological disorders, or other diseases that impede the completion of evaluation; 4. Neurosurgery; 5. Presence of contraindications to rTMS treatment, including epilepsy, pregnant or lactating women, or with a metal or electric implanted device (e.g., deep brain stimulator, ventriculoperitoneal shunt, aneurysm clip, pacemaker, cochlear implant, or surgical staples on the scalp); 6. Other situations that are deemed unsuitable for inclusion in the study.
Where it's running
-
Peking University First Hospital
Beijing, Beijing Municipality, China Recruiting -
Peking University Shenzhen Hospital
Shenzhen, Guangzhou, China Not yet recruiting -
Xijing Hospital, Air Force Medical University
Xi'an, Shannxi, China Not yet recruiting
Study contacts
- Principal investigator: Dong-Xin Wang, MD, PhD — Peking University First Hospital
- Study coordinator: Dong-Xin Wang, MD, PhD
- Email: wangdongxin@hotmail.com
- Phone: 8610 83572784
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How anesthesia type affects thinking after bariatric sleeve surgery
This observational study tests whether intravenous anesthesia or inhalational anesthesia leads to different cognitive outcomes after sleeve gastrectomy in adults with obesity.
-
Digital sleep optimization for older surgical patients
This study is testing if a digital sleep program can help older patients sleep better and think clearer after major joint surgery compared to regular sleep education.
-
Biomarkers That Signal Silent Strokes in High-Risk Cardiac Procedures
This study tests whether blood biomarkers NSE and NFLs can predict silent brain injuries and later cognitive problems in adults having high-risk transcatheter heart procedures.
-
Blood-based tests and digital cognitive checks to help triage dementia
This study tests whether adding blood biomarkers, APOE4 genetic info, and digital cognitive tests can help dementia diagnosis be faster in NHS Memory Clinics.
-
Cardiovascular and Cognitive Health Initiative
This study tests whether targeted cognitive and heart-health interventions can help improve thinking skills in adults with cardiovascular disease.
-
Synbiotic blend of LA-5 and agave inulin for mild cognitive impairment
This pilot crossover study tests whether a synbiotic containing Lactobacillus acidophilus LA-5 and agave inulin can help adults aged 60–75 with mild cognitive impairment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.